Skip to content

Prof. Parisi Vincenzo

Head of the Research Unit
Parisi Vincenzo

Medical activity: Acting Head of the Ophthalmology Unit of the IRCCS Bietti Foundation. Works at IRCCS G.B. Bietti  in the offices Via Livenza, 3 and  Via di santo Stefano Rotondo 6, at Presidio Ospedaliero Britannico, Rome

Scientific publication  : PubMed

linkedin: Vincenzo Parisi

E-Mail: vincenzo.parisi@fondazionebietti.it

  • High-school Diploma, Scientific lyceum in 1980 with 60/60; graduated at the faculty of Medicine of the
  • University of Rome “La Sapienza” on 03/11/1986 (110/110 and honors)
  • Ophthalmology Residency completed at the University of Rome “Tor Vergata” on 11/07/90
  • (50/50 cum laude).
  • From September 1989 to December 1991 research fellowship at the CNR, Institute of Neurophysiology in
  • Pisa directed by Prof. Lamberto Maffei, carrying out studies on the role of Nerve Growth Factor in plasticity of the visual system.
  • Italian medicine board certified member (1987, license number:38147, Rome, Italy
  • From November 2020 certified Full Professor in Ophthalmology

–          Since 1989 to1993, scientific collaborations and consultant at the Medical-Legal Institute (IML) of the Air   Force in Rome

–          In 1992, clinical and research fellowship at the Ophthalmology Clinic of the University of “Tor Vergata”,  directed by Prof. Massimo G. Bucci.

–          From 1994 to 2002, Prof. Massimo G. Bucci, Director of the Ophthalmology Clinic of the University of   Rome Tor Vergata, designated him to take care of the department of neurophysiology and neurophthalmology.

–          Since 1993 to 2003, clinical and research fellowship at the Fatebenefratelli Association for Research  (AFAR), Rome.

–          In 1998, he began his collaboration with the Foundation for the Study and Research in Ophthalmology GB  Bietti- ONLUS, under the supervision of Prof. Mario Stirpe (Chairman) and Prof. Massimo G. Bucci (Scientific Director).

–          Since 2001 to 2005, the GB Bietti Foundation gave him the role of “Editor” (head of research activity with  the purpose of publications on international journals).

Since 2005-2017, the year of the acknowledgement of the GB Bietti Foundation as Institute of Hospital and Care with Scientific purpose (IRCCS), he become a member  of the scientific Committee and  Head of the Research Unit “Neurophysiology of Vision and Neuro-ophthalmology”.

–          From 1999 to 2010: Teacher of  “Neurophthalmology” at the II School in Neurology at the University of Rome La Sapienza.

–           From 2002 to 2010 Professor of Neurophthalmology at the School of Specialization in Neurology at the University of Rome “Tor Vergata”.

–            From 2017 to 2019 Professor of Visual Neurophysiology at the II Level Master of Legal Ophthalmology,  University of Rome La Sapienza

– He personally presented 202 communications at national congresses and 93 at International Congresses.
– He is author of 311 scientific publications including 172 on international journals (167 with Impact Factor). Total Impact Factor: 570.205; Personal H-index: 50 (Google Scholar)42 (Scopus)

  • Italian Ophthalmological Society
  • Italian Society of Clinical Neurophysiology
  • Italian Association of Glaucoma Study
  • Italian Society of Neuro-ophthalmology
  • Italian Retina Society
  • The Association for Research in Vision and Ophthalmology (ARVO)
  • New York Academy of Sciences
  • International  Society  for  Clinical  Electrophysiology  of  Vision (ISCEV)
  • Founding Member of the Neuroprotection Interdisciplinary Group

Institutional Research Projects:

– 2005-2007, Principal Investigator of the Project of the Ministry of Health “Ricerca Finalizzata”, with the topic: “Potential therapeutic role of Nerve Growth Factor in glaucoma: studies in animal models and humans.” This project, lasting 36 months, was completed in 2009 and resulted in qualified scientific papers published on PNAS (2009), Vision Research (2009), Journal of Glaucoma (2011).

– 2007-2010, Principal Investigator of the Project of the Ministry of Health “Ricerca Finalizzata”, with the topic: “Leber’s optic neuropathy: from the early diagnosis to the rehabilitation”. This project, lasting 36 months, was completed in 2009 and resulted in qualified scientific papers published on European Journal of Ophthalmology (2012)  and Investigative Ophthalmology and Visual Science Vision Research (2013).

– 2012, Principal Investigator of the AIFA project entitled “Evaluation of potential neuroprotective action of minocycline in addition to topical hypotonic therapy for the maintenance of functional impairment of vision in patients with Glaucoma”

– 2014, Principal Investigator of the Project of the Ministry of Health “Ricerca Finalizzata”, with the topic: ” Morphofunctional visual pathways evaluation in multiple sclerosis: possible identification of neurodegenerative biomarkers”.

 

Principal Investigator in Clinical Trials:

  • 1996-1998, Principal Investigator of the No-profit clinical study “Evaluation of the effects of  Citicoline intramuscularly administered on the retinal function and on the neural conduction along the visual pathways in glaucomatous patients

 

  • 1996-1998, Principal Investigator of the No-profit clinical study. “Evaluation of the effects of Nicergoline on the retinal function and on the neural conduction along the visual pathways in glaucomatous patients.

 

  • 2000-2002, Principal Investigator of the No-profit clinical study. “Comparison of the effects of  Citicoline intramuscularly administered and orally adimisted on the retinal function and on the neural conduction along the visual pathways in glaucomatous patients.

 

  • 2006-2007, Principal Investigator of the No-profit clinical study. “Evaluation of the effects of epigallocatechin gallate on the retinal function and on the neural conduction along the visual pathways in glaucomatous patients”.

 

  • 2008-2012, Principal Investigator of the No-profit clinical study. “Evaluation of the effects of Coezime Q10 on the retinal function and on the neural conduction along the visual pathways in glaucomatous patients”.

 

  • 2009-2013, Principal Investigator of sponsorized study “Evaluation of the effects of oral administration of L-acetil carnitine on the visual function in patients affected by Leber Hereditary Optic Neuropathy”

 

  • 2013, Principal Investigator of sponsorized study “LHON Historical Case Record Survey”

 

 

 

  • 2012-2014, Principal Investigator of No-profit clinical study. “Evaluation of the potential neuroprotective action of Citicoline added to the topic hypotonic therapy for the maintenance or amelioration of the visual functional deficit in patients affected by glaucoma”

 

  • 2017-2019,  Principal Investigator of No-profit clinical study. Neural Conduction Along the Visual Pathways After Oral Treatment With Citicoline in Patients With Optic Nerve Diseases.

 

  • 2017-2019,  Principal Investigator of No-profit clinical study. “Evaluation of the potential neuroprotective action of Citicoline in liposomial formulation added to the topic hypotonic therapy for the maintenance or amelioration of the visual functional deficit in patients affected by glaucoma”

 

  • 2018-2019,  Co-Principal Investigator of sponsorized study “Evaluation of the effects of MACUPREV® on the visual function in patients affected by age-ralted maculopathy

 

2021- Principal Investigator of the clinical study “Modulation of neuronal connectivity along the visual pathways in glaucomatous patients by treatment with Citicoline in oral solution: multimodal morpho-functional study”

  • Since June 1997, “expert reviewer” for Clinical Neurophysiology
  • Since 1999 “expert reviewer” for Investigative Ophthalmology and Visual Science
  • Since 2000 “expert reviewer” for Documenta Ophthalmologica Ophthalmic and Physiological  Optics
  • Since 2002 “expert reviewer” for Current Eye Research, European Journal of Ophthalmology, Optics pathophysiological.
  • Since 2004 “expert reviewer” for Archive’s of Ophthalmology
  • Since 2004 “expert reviewer” for Brain and Ophthalmology
  • Since 2006 “expert reviewer” for Vision Research, European Journal of Neurology, British Journal of Ophthalmology
  • Since 2007 “expert reviewer” for Expert Review of Ophthalmology.
  • From 2013’s “expert reviewer” for the Journal of Translational Medicine
  • From 2014’s “expert reviewer” for Experimental Eye Research
  • From 2016’s “expert reviewer” for Journal of Glaucoma, Journal of Alzheimer’s Disease
  • From 2020’s “expert reviewer” for Scientific Report, Frontiers in Neurology
  • Since 1999 ” guest Editorial Board Member” for Investigative Ophthalmology and Visual Science
  • Editorial Board Member” di  Ophthalmology@Pointof Care
  • -2020 Editorial Board Member of Journal of Clinical Medicine e Frontiers of Neurology
  • In 1991 he won a scholarship from the National Research Council for “research in the field of disciplines related to the National Committee for technological research and innovation.”
  • In December 1993 he won a scholarship from the International Foundation Fatebenefratelli for “research in the field of retinal pathophysiology.”
  • In January 1998, his biography was published in WHO’S WHO IN SCIENCE AND ENGINEERING with the following reason “demonstrated considerable knowledge and appreciation recognized in their field of scientific application that contributed significantly to the improvement of society”.
  • In 1998 he won the award of the Italian Society of Ophthalmology for clinical research.
  • In 1999 and 2000, 2001 and 2002 and 2003 he won scholarships to the International Foundation Fatebenefratelli “Electrophysiology of Vision” and “Vision”.
  • In 2007, 2008 and 2010 he was nominated by the Association for Research in Vision and Ophthalmology (ARVO) “moderator” for the “Morphology, Electrophysiology and Visual Function” section.
Skip to content